{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:01:12Z","timestamp":1768568472038,"version":"3.49.0"},"posted":{"date-parts":[[2024,8,23]]},"group-title":"Neurology","reference-count":81,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:00:00Z","timestamp":1724371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,8,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>The varicella zoster virus, a neurotropic herpesvirus, has been hypothesized to play a role in the pathophysiology of dementia, such as through neuroinflammatory processes or intracerebral vasculopathy. Using unique natural experiments, our group has previously found that live-attenuated herpes zoster (HZ) vaccination reduced the incidence of new diagnoses of dementia in both Wales and Australia. To inform further research and ultimately clinical care, it is crucial to understand at which stage of the disease course of dementia the HZ vaccine has its effect. Representing the two opposing ends of the dementia disease course as it can be ascertained from electronic health record data, the aims of this study were twofold: to determine the effect of HZ vaccination on i) new diagnoses of mild cognitive impairment (MCI) among individuals without any record of cognitive impairment, and ii) deaths due to dementia among individuals living with dementia. Our approach took advantage of the fact that at the time of the start date (September 1 2013) of the HZ vaccination program in Wales, individuals who had their eightieth birthday just after this date were eligible for HZ vaccination for one year whereas those who had their eightieth birthday just before were ineligible and remained ineligible for life. This eligibility rule created comparison groups just on either side of the September 2 1933 date-of-birth eligibility threshold who differed in their age by merely a week but had a large difference in their probability of receiving HZ vaccination. The key strength of our study is that these comparison groups should be similar in their health characteristics and behaviors except for a minute difference in age. We used regression discontinuity analysis to estimate the difference in our outcomes between individuals born just on either side of the date-of-birth eligibility threshold for HZ vaccination. Our dataset consisted of detailed country-wide electronic health record data from primary care in Wales, linked to hospital records and death certificates. We restricted our dataset to individuals born between September 1 1925 and September 1 1942. Among our study cohort of 282,557 without any record of cognitive impairment at baseline, HZ vaccination eligibility and receipt reduced the incidence of a new MCI diagnosis by 1.5 (95% CI: 0.5 \u2013 2.9, p=0.006) and 3.1 (95% CI: 1.0 \u2013 6.2, p=0.007) percentage points over nine years, respectively. Similarly, among our study cohort of 14,350 individuals who were living with dementia at baseline, being eligible for and receiving HZ vaccination reduced deaths due to dementia by 8.5 (95% CI: 0.6 \u2013 18.5, p=0.036) and 29.5 (95% CI: 0.6 \u2013 62.9, p=0.046) percentage points over nine years, respectively. Except for dementia, HZ vaccination did not have an effect on any of the ten most common causes of morbidity and mortality among adults aged 70 years and older in Wales in either of our two study cohorts. The protective effects of HZ vaccination for both MCI and deaths due to dementia were larger among women than men. Our findings suggest that the live-attenuated HZ vaccine has benefits for the dementia disease process at both ends of the disease course of dementia.<\/jats:p>","DOI":"10.1101\/2024.08.23.24312457","type":"posted-content","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T21:45:11Z","timestamp":1724449511000},"source":"Crossref","is-referenced-by-count":1,"title":["The effect of herpes zoster vaccination at different stages of the disease course of dementia: Two quasi-randomized studies"],"prefix":"10.64898","author":[{"given":"Min","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Eyting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Bommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0634-8548","authenticated-orcid":false,"given":"Haroon","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8878-5505","authenticated-orcid":false,"given":"Pascal","family":"Geldsetzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024082708000610000_2024.08.23.24312457v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00549-x"},{"key":"2024082708000610000_2024.08.23.24312457v1.2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3233\/JAD-160152","article-title":"Microbes and Alzheimer\u2019s Disease","volume":"51","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"2024082708000610000_2024.08.23.24312457v1.3","doi-asserted-by":"crossref","unstructured":"D. P. Devanand , Viral Hypothesis and Antiviral Treatment in Alzheimer\u2019s Disease. Curr Neurol Neurosci Rep 18, 55 (2018).","DOI":"10.1007\/s11910-018-0863-1"},{"key":"2024082708000610000_2024.08.23.24312457v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.06.3040"},{"key":"2024082708000610000_2024.08.23.24312457v1.5","doi-asserted-by":"crossref","unstructured":"A. Arvin , G. Campadelli-Fiume , E. Mocarski , P. S. Moore , B. Roizman , R. Whitley , K. Yamanishi , Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis (Cambridge University Press, 2007).","DOI":"10.1017\/CBO9780511545313"},{"key":"2024082708000610000_2024.08.23.24312457v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.06.030"},{"key":"2024082708000610000_2024.08.23.24312457v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00770-5"},{"key":"2024082708000610000_2024.08.23.24312457v1.8","doi-asserted-by":"crossref","first-page":"e1103","DOI":"10.1212\/NXI.0000000000001103","article-title":"Targeted RNA Sequencing of VZV-Infected Brain Vascular Adventitial Fibroblasts Indicates That Amyloid May Be Involved in VZV Vasculopathy","volume":"9","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2024082708000610000_2024.08.23.24312457v1.9","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-014-0206-2"},{"key":"2024082708000610000_2024.08.23.24312457v1.10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002175"},{"key":"2024082708000610000_2024.08.23.24312457v1.11","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy425"},{"key":"2024082708000610000_2024.08.23.24312457v1.12","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000304747.38502.e8"},{"key":"2024082708000610000_2024.08.23.24312457v1.13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182267bfa"},{"key":"2024082708000610000_2024.08.23.24312457v1.14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31827b1ab9"},{"key":"2024082708000610000_2024.08.23.24312457v1.15","doi-asserted-by":"crossref","first-page":"2216625","DOI":"10.1080\/21645515.2023.2216625","article-title":"Do vaccinations influence the development of Alzheimer disease?","volume":"19","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"2024082708000610000_2024.08.23.24312457v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30742-X"},{"key":"2024082708000610000_2024.08.23.24312457v1.17","doi-asserted-by":"publisher","DOI":"10.1007\/S40264-023-01295-3"},{"key":"2024082708000610000_2024.08.23.24312457v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/S41577-020-0338-X"},{"key":"2024082708000610000_2024.08.23.24312457v1.19","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv125"},{"key":"2024082708000610000_2024.08.23.24312457v1.20","doi-asserted-by":"crossref","unstructured":"M. Eyting , M. Xie , S. He\u00df , P. Geldsetzer , Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases. medRxiv, 2023.05.23.23290253 (2023).","DOI":"10.1101\/2023.05.23.23290253"},{"key":"2024082708000610000_2024.08.23.24312457v1.21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3233\/JAD-221231","article-title":"The Impact of Routine Vaccinations on Alzheimer\u2019s Disease Risk in Persons 65 Years and Older: A Claims-Based Cohort Study using Propensity Score Matching","volume":"95","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"2024082708000610000_2024.08.23.24312457v1.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-045871"},{"key":"2024082708000610000_2024.08.23.24312457v1.23","doi-asserted-by":"crossref","first-page":"e0257405","DOI":"10.1371\/journal.pone.0257405","article-title":"Impact of herpes zoster vaccination on incident dementia: A retrospective study in two patient cohorts","volume":"16","year":"2021","journal-title":"PLoS One"},{"key":"2024082708000610000_2024.08.23.24312457v1.24","doi-asserted-by":"crossref","first-page":"e12293","DOI":"10.1002\/trc2.12293","article-title":"Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020","volume":"8","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"2024082708000610000_2024.08.23.24312457v1.25","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/jgs.17606","article-title":"Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations","volume":"70","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"2024082708000610000_2024.08.23.24312457v1.26","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1186\/s12889-023-16768-4","article-title":"The association of herpes zoster and influenza vaccinations with the risk of developing dementia: a population-based cohort study within the UK Clinical Practice Research Datalink","volume":"23","year":"2023","journal-title":"BMC Public Health"},{"key":"2024082708000610000_2024.08.23.24312457v1.27","doi-asserted-by":"crossref","first-page":"112411","DOI":"10.1016\/j.exger.2024.112411","article-title":"Associations of infections and vaccines with Alzheimer\u2019s disease point to a role of compromised immunity rather than specific pathogen in AD","volume":"190","year":"2024","journal-title":"Exp Gerontol"},{"key":"2024082708000610000_2024.08.23.24312457v1.28","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12622"},{"key":"2024082708000610000_2024.08.23.24312457v1.29","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2021-217090"},{"key":"2024082708000610000_2024.08.23.24312457v1.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03201-5"},{"key":"2024082708000610000_2024.08.23.24312457v1.31","unstructured":"UK Health Security Agency, Shingles: guidance and vaccination programme, Shingles: guidance and vaccination programme (2021). https:\/\/www.gov.uk\/government\/collections\/shingles-vaccination-programme."},{"key":"2024082708000610000_2024.08.23.24312457v1.32","doi-asserted-by":"crossref","unstructured":"C. Remschmidt , O. Wichmann , T. Harder , Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect Dis 15, 429 (2015).","DOI":"10.1186\/s12879-015-1154-y"},{"key":"2024082708000610000_2024.08.23.24312457v1.33","doi-asserted-by":"crossref","unstructured":"M. Pomirchy , C. Bommer , F. Pradella , F. Michalik , R. Peters , P. Geldsetzer , Herpes zoster vaccination and new diagnoses of dementia: A quasi-randomized study in Australia. medRxiv, 2024.06.27.24309563 (2024).","DOI":"10.1101\/2024.06.27.24309563"},{"key":"2024082708000610000_2024.08.23.24312457v1.34","first-page":"1","article-title":"United Kingdom: Health System Review","volume":"24","year":"2022","journal-title":"Health Syst Transit"},{"key":"2024082708000610000_2024.08.23.24312457v1.35","unstructured":"Swansea University, SAIL Databank. https:\/\/saildatabank.com\/."},{"key":"2024082708000610000_2024.08.23.24312457v1.36","doi-asserted-by":"crossref","unstructured":"D. V. Ford , K. H. Jones , J.-P. Verplancke , R. A. Lyons , G. John , G. Brown , C. J. Brooks , S. Thompson , O. Bodger , T. Couch , K. Leake , The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res 9, 157 (2009).","DOI":"10.1186\/1472-6963-9-157"},{"key":"2024082708000610000_2024.08.23.24312457v1.37","unstructured":"SAIL Databank, Welsh Longitudinal General Practice Dataset (WLGP) - Welsh Primary Care (2023). https:\/\/web.www.healthdatagateway.org\/dataset\/33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2."},{"key":"2024082708000610000_2024.08.23.24312457v1.38","unstructured":"Welsh Results Reports Service (WRRS). https:\/\/web.www.healthdatagateway.org\/dataset\/71d37610-ac55-432d-82a3-bdb04407acd8."},{"key":"2024082708000610000_2024.08.23.24312457v1.39","doi-asserted-by":"publisher","DOI":"10.14236\/jhi.v19i3.811"},{"key":"2024082708000610000_2024.08.23.24312457v1.40","unstructured":"Digital Health and Care Wales, Welsh Demographic Service Dataset (WDSD) (2022). https:\/\/web.www.healthdatagateway.org\/dataset\/cea328df-abe5-48fb-8bcb-c0a5b6377446#."},{"key":"2024082708000610000_2024.08.23.24312457v1.41","unstructured":"Digital Health and Care Wales, Patient Episode Database for Wales, Digital Health and Care Wales (2020). https:\/\/dhcw.nhs.wales\/information-services\/health-intelligence\/pedw-data-online\/."},{"key":"2024082708000610000_2024.08.23.24312457v1.42","unstructured":"Digital Health and Care Wales, Outpatient Database for Wales (OPDW) (2022). https:\/\/web.www.healthdatagateway.org\/dataset\/d331159b-b286-4ab9-8b36-db39123ec229."},{"key":"2024082708000610000_2024.08.23.24312457v1.43","unstructured":"Public Health Wales, Welsh Cancer Intelligence and Surveillance Unit (WCISU), Public Health Wales (2023). https:\/\/phw.nhs.wales\/services-and-teams\/welsh-cancer-intelligence-and-surveillance-unit-wcisu\/."},{"key":"2024082708000610000_2024.08.23.24312457v1.44","unstructured":"Digital Health and Care Wales, Annual District Death Extract (ADDE) (2023). https:\/\/web.www.healthdatagateway.org\/dataset\/15cf4241-abad-4dcc-95b0-8cd7c02be999."},{"key":"2024082708000610000_2024.08.23.24312457v1.45","unstructured":"NHS Digital, Attribution Data Set GP-Registered Populations Scaled to ONS Population Estimates - 2011. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/attribution-dataset-gp-registered-populations\/attribution-data-set-gp-registered-populations-scaled-to-ons-population-estimates-2011."},{"key":"2024082708000610000_2024.08.23.24312457v1.46","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-008149"},{"key":"2024082708000610000_2024.08.23.24312457v1.47","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/alz.12638","article-title":"2022 Alzheimer\u2019s disease facts and figures","volume":"18","author":"Alzheimer\u2019s Association","year":"2022","journal-title":"Alzheimers Dement"},{"key":"2024082708000610000_2024.08.23.24312457v1.48","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25123"},{"key":"2024082708000610000_2024.08.23.24312457v1.49","doi-asserted-by":"publisher","DOI":"10.1002\/ANA.25380"},{"key":"2024082708000610000_2024.08.23.24312457v1.50","unstructured":"Office for National Statistics, Impact of registration delays on mortality statistics in England and Wales - Office for National Statistics. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/articles\/impactofregistrationdelaysonmortalitystatisticsinenglandandwales\/latest."},{"key":"2024082708000610000_2024.08.23.24312457v1.51","doi-asserted-by":"crossref","unstructured":"M. Villamizar-Villegas , F. A. Pinzon-Puerto , M. A. Ruiz-Sanchez , A comprehensive history of regression discontinuity designs: An empirical survey of the last 60 years. Journal of Economic Surveys Epub ahead of print (2022).","DOI":"10.1111\/joes.12461"},{"key":"2024082708000610000_2024.08.23.24312457v1.52","doi-asserted-by":"crossref","unstructured":"M. D. Cattaneo , N. Idrobo , R. Titiunik , A Practical Introduction to Regression Discontinuity Designs: Foundations (Cambridge University Press, Cambridge, 2020).","DOI":"10.1017\/9781108684606"},{"key":"2024082708000610000_2024.08.23.24312457v1.53","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1002\/sim.9861","article-title":"A guide to regression discontinuity designs in medical applications","volume":"42","year":"2023","journal-title":"Statistics in Medicine"},{"key":"2024082708000610000_2024.08.23.24312457v1.54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jeconom.2007.05.001"},{"key":"2024082708000610000_2024.08.23.24312457v1.55","doi-asserted-by":"publisher","DOI":"10.3982\/ECTA11757"},{"key":"2024082708000610000_2024.08.23.24312457v1.56","unstructured":"A. Gelman , G. Imbens , Why High-Order Polynomials Should Not Be Used in Regression Discontinuity Designs. Journal of Business & Economic Statistics, 1\u201310 (2017)."},{"key":"2024082708000610000_2024.08.23.24312457v1.57","unstructured":"Global Burden of Disease Project 2019, GBD Compare (2020). http:\/\/vizhub.healthdata.org\/gbd-compare."},{"key":"2024082708000610000_2024.08.23.24312457v1.58","unstructured":"Statistical Directorate, \u201cWelsh Index of Multiple Deprivation 2011: Summary Report\u201d (Welsh Government, Cardiff, 2011); https:\/\/www.gov.wales\/welsh-index-multiple-deprivation-full-index-update-ranks-2011."},{"key":"2024082708000610000_2024.08.23.24312457v1.59","doi-asserted-by":"crossref","first-page":"e011146","DOI":"10.1136\/bmjopen-2016-011146","article-title":"Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis","volume":"7","year":"2017","journal-title":"BMJ Open"},{"key":"2024082708000610000_2024.08.23.24312457v1.60","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291712001122"},{"key":"2024082708000610000_2024.08.23.24312457v1.61","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1007\/s10072-022-06056-1","article-title":"How long does it take to diagnose young-onset dementia? A comparison with late-onset dementia","volume":"43","year":"2022","journal-title":"Neurol Sci"},{"key":"2024082708000610000_2024.08.23.24312457v1.62","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14067"},{"key":"2024082708000610000_2024.08.23.24312457v1.63","doi-asserted-by":"publisher","DOI":"10.1159\/000487233"},{"key":"2024082708000610000_2024.08.23.24312457v1.64","unstructured":"Centers for Disease Control and Prevention, Archived CDC Vaccine Price List as of June 1, 2018, Adult Vaccine Price List (2022). https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/2018\/2018-06-01.html."},{"key":"2024082708000610000_2024.08.23.24312457v1.65","first-page":"930","article-title":"Costs of adult vaccination in medical settings and pharmacies: an observational study","volume":"20","year":"2014","journal-title":"J Manag Care Spec Pharm"},{"key":"2024082708000610000_2024.08.23.24312457v1.66","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/M18-2347","article-title":"A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations","volume":"170","year":"2019","journal-title":"Ann Intern Med"},{"key":"2024082708000610000_2024.08.23.24312457v1.67","doi-asserted-by":"crossref","unstructured":"H. Bricout , M. Haugh , O. Olatunde , R. G. Prieto , Herpes zoster-associated mortality in Europe: a systematic review. BMC Public Health 15, 466 (2015).","DOI":"10.1186\/s12889-015-1753-y"},{"key":"2024082708000610000_2024.08.23.24312457v1.68","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab387"},{"key":"2024082708000610000_2024.08.23.24312457v1.69","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268803001523"},{"key":"2024082708000610000_2024.08.23.24312457v1.70","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa005"},{"key":"2024082708000610000_2024.08.23.24312457v1.71","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/ene.14174","article-title":"Sex and gender differences in Alzheimer\u2019s disease: current challenges and implications for clinical practice: Position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology","volume":"27","year":"2020","journal-title":"Eur J Neurol"},{"key":"2024082708000610000_2024.08.23.24312457v1.72","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-018-0032-9"},{"key":"2024082708000610000_2024.08.23.24312457v1.73","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000401"},{"key":"2024082708000610000_2024.08.23.24312457v1.74","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30367-6"},{"key":"2024082708000610000_2024.08.23.24312457v1.75","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1093\/ageing\/afae030","article-title":"Nutrition for dementia prevention: a state of the art update for clinicians","volume":"53","year":"2024","journal-title":"Age Ageing"},{"key":"2024082708000610000_2024.08.23.24312457v1.76","unstructured":"M. A. Hernan , J. M. Robins , Causal Inference: What If (Chapman & Hall\/CRC, Boca Raton, FL , 1st Edition., 2020)."},{"key":"2024082708000610000_2024.08.23.24312457v1.77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2012.07.059"},{"key":"2024082708000610000_2024.08.23.24312457v1.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.07.035"},{"key":"2024082708000610000_2024.08.23.24312457v1.79","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3233\/JAD-220287","article-title":"Potential Involvement of Varicella Zoster Virus in Alzheimer\u2019s Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1","volume":"88","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"2024082708000610000_2024.08.23.24312457v1.80","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/vaccines9060679","article-title":"Overwhelming Evidence for a Major Role for Herpes Simplex Virus Type 1 (HSV1) in Alzheimer\u2019s Disease (AD); Underwhelming Evidence against","volume":"9","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2024082708000610000_2024.08.23.24312457v1.81","doi-asserted-by":"crossref","first-page":"25151355221084535","DOI":"10.1177\/25151355221084535","article-title":"Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review","volume":"10","year":"2022","journal-title":"Ther Adv Vaccines Immunother"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.08.23.24312457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:10:09Z","timestamp":1768507809000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.08.23.24312457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,23]]},"references-count":81,"URL":"https:\/\/doi.org\/10.1101\/2024.08.23.24312457","relation":{},"subject":[],"published":{"date-parts":[[2024,8,23]]},"subtype":"preprint"}}